Loading publications…
The last 5 uploaded publications
Implication of Apolipoprotein E gene variants in pediatric-onset multiple sclerosis: Possible association with disease susceptibility and its clinical characteristics, in a Hellenic cohort
Charalampos Skarlis, Nikolaos Markoglou, Artemios Artemiadis, Maria Gontika, Georgios Koutsis, George Chrousos, Maria Anagnostouli (2024). Implication of Apolipoprotein E gene variants in pediatric-onset multiple sclerosis: Possible association with disease susceptibility and its clinical characteristics, in a Hellenic cohort. , 90, DOI: https://doi.org/10.1016/j.msard.2024.105797.
Article74 days agoThe impact of HLA-DRB1 alleles in a Hellenic, Pediatric-Onset Multiple Sclerosis cohort: Implications on clinical and neuroimaging profile
Charalampos Skarlis, Nikolaos Markoglou, Maria Gontika, Artemios Artemiadis, Maria-Roser Pons, Leonidas Stefanis, Marinos C. Dalakas, George Chrousos, Maria Anagnostouli (2024). The impact of HLA-DRB1 alleles in a Hellenic, Pediatric-Onset Multiple Sclerosis cohort: Implications on clinical and neuroimaging profile. , 45(11), DOI: https://doi.org/10.1007/s10072-024-07619-0.
Article74 days agoFingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data
Maria Gontika, Charalampos Skarlis, Nikolaos Markoglou, Maria‐Eleftheria Evangelopoulos, Georgios Velonakis, George Chrousos, Marinos C. Dalakas, Leonidas Stefanis, Maria Anagnostouli (2021). Fingolimod as a first- or second-line treatment in a mini-series of young Hellenic patients with adolescent-onset multiple sclerosis: focus on immunological data. , 43(4), DOI: https://doi.org/10.1007/s10072-021-05623-2.
Article74 days agoFirst-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center
Charalampos Skarlis, Nikolaos Markoglou, Maria Gontika, Anastasia Bougea, Serafeim Katsavos, Artemios Artemiadis, George Chrousos, Marinos C. Dalakas, Leonidas Stefanis, Maria Anagnostouli (2022). First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center. , 44(2), DOI: https://doi.org/10.1007/s10072-022-06431-y.
Article74 days agoNatalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions—a single-center retrospective observational study
Maria Gontika, Charalampos Skarlis, Nikolaos Markoglou, Dimitrios Tzanetakos, Aglaia G Vakrakou, Panagiotis Toulas, Georgios Koutsis, Maria‐Eleftheria Evangelopoulos, Roser Pons, Efthimios Dardiotis, George Chrousos, Marinos C. Dalakas, Leonidas Stefanis, Maria Anagnostouli (2022). Natalizumab therapy in patients with pediatric-onset multiple sclerosis in Greece: clinical and immunological insights of time-long administration and future directions—a single-center retrospective observational study. , 395(8), DOI: https://doi.org/10.1007/s00210-022-02238-y.
Article74 days ago